Refreshing results…
Author Correction: Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer
UploadTherapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma
Download from doi.orgArgonaute 2 modulates EGFR–RAS signaling to promote mutant HRAS and NRAS-driven malignancies
Download from academic.oup.comTargeting SWI/SNF ATPases in enhancer-addicted prostate cancer
Download from www.nature.comMissing publications? Search for publications with a matching author name.